Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
3.982
-0.289 (-6.76%)
At close: Feb 21, 2025, 4:00 PM
3.990
+0.009 (0.21%)
After-hours: Feb 21, 2025, 4:15 PM EST

Arcadia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Feb '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
537233447
Upgrade
Market Cap Growth
0.20%-47.96%-71.05%-32.20%-28.18%213.03%
Upgrade
Enterprise Value
-1-11-14-83419
Upgrade
Last Close Price
3.983.1310.8441.60101.20219.20
Upgrade
PS Ratio
0.990.781.343.404.2440.53
Upgrade
PB Ratio
0.530.270.320.741.195.69
Upgrade
P/TBV Ratio
0.360.270.320.751.266.15
Upgrade
EV/Sales Ratio
----4.2416.57
Upgrade
Debt / Equity Ratio
0.030.080.100.110.330.27
Upgrade
Asset Turnover
0.280.180.140.150.200.04
Upgrade
Inventory Turnover
2.502.001.062.183.167.78
Upgrade
Quick Ratio
3.203.385.195.964.294.54
Upgrade
Current Ratio
4.604.176.037.025.024.98
Upgrade
Return on Equity (ROE)
-67.08%-31.72%-14.62%-54.01%-32.68%-273.15%
Upgrade
Return on Assets (ROA)
-44.71%-15.04%-12.38%-33.30%-26.92%-44.34%
Upgrade
Return on Capital (ROIC)
-63.71%-19.96%-15.71%-41.98%-44.39%-107.34%
Upgrade
Earnings Yield
-107.22%-402.29%-230.24%-63.54%-13.68%-60.79%
Upgrade
FCF Yield
-213.06%-439.06%-210.37%-116.49%-95.66%-39.41%
Upgrade
Buyback Yield / Dilution
-27.94%-106.37%-12.66%-113.68%-56.51%-68.94%
Upgrade
Total Shareholder Return
-27.94%-106.37%-12.66%-113.68%-56.51%-68.94%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.